Haleon Yönetim

Yönetim kriter kontrolleri 1/4

Haleon CEO'su Brian McNamara, Jul2021 tarihinde atandı, in görev süresi 3.33 yıldır. in toplam yıllık tazminatı £ 5.76M olup, şirket hissesi ve opsiyonları dahil olmak üzere 21.7% maaş ve 78.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.014% ine doğrudan sahiptir ve bu hisseler £ 4.79M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 0.3 yıl ve 2.3 yıldır.

Anahtar bilgiler

Brian McNamara

İcra Kurulu Başkanı

UK£5.8m

Toplam tazminat

CEO maaş yüzdesi	21.7%
CEO görev süresi	3.3yrs
CEO sahipliği	0.01%
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	2.3yrs

Son yönetim güncellemeleri

Recent updates

Haleon plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Nov 03

Haleon plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 04

Haleon plc's (LON:HLN) Popularity With Investors Is Clear

Mar 06

Calculating The Intrinsic Value Of Haleon plc (LON:HLN)

Jan 21

Haleon (LON:HLN) Might Have The Makings Of A Multi-Bagger

Nov 24

Estimating The Intrinsic Value Of Haleon plc (LON:HLN)

Sep 10

Haleon (LON:HLN) Shareholders Will Want The ROCE Trajectory To Continue

Aug 14

Haleon plc's (LON:HLN) Intrinsic Value Is Potentially 23% Below Its Share Price

May 03

Haleon plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 22

Investors Can Find Comfort In Haleon's (LON:HLN) Earnings Quality

Mar 10

Calculating The Fair Value Of Haleon plc (LON:HLN)

Dec 18

CEO Tazminat Analizi

Brian McNamara'un ücretlendirmesi Haleon'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	UK£1b
Jun 30 2024	n/a	n/a	UK£1b
Mar 31 2024	n/a	n/a	UK£1b
Dec 31 2023	UK£6m	UK£1m	UK£1b
Sep 30 2023	n/a	n/a	UK£1b
Jun 30 2023	n/a	n/a	UK£1b
Mar 31 2023	n/a	n/a	UK£1b
Dec 31 2022	UK£2m	UK£719k	UK£1b

Tazminat ve Piyasa: Brian 'ın toplam tazminatı ($USD 7.23M ) UK pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 5.66M ).

Tazminat ve Kazançlar: Brian şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.

CEO

Brian McNamara (58 yo)

3.3yrs

Görev süresi

UK£5,763,000

Tazminat

Mr. Brian James McNamara serves as Independent Director at Mondelez International, Inc. since February 01, 2024. He serves as Chief Executive Officer at Haleon plc and serves as its Executive Director sinc...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Brian McNamara	CEO & Executive Director	3.3yrs	UK£5.76m	0.014% £ 4.8m
Tobias Hestler	Executive Officer	no data	UK£2.05m	0.00072% £ 245.7k
Dawn Allen	CFO & Director	no data	Veri yok	Veri yok
Claire Dickson	Chief Digital & Technology Officer	less than a year	Veri yok	Veri yok
Sonya Ghobrial	Head of Investor Relations	no data	Veri yok	Veri yok
Adrian Morris	General Counsel	less than a year	Veri yok	Veri yok
Tamara Rogers	Chief Marketing Officer	2.9yrs	Veri yok	0.00032% £ 109.2k
Line De Decker	Chief Human Resources Officer	less than a year	Veri yok	Veri yok
Filippo Lanzi	President of EMEA & LatAm	no data	Veri yok	0.00077% £ 262.8k
Keith Choy	President of Asia Pacific	no data	Veri yok	0.00063% £ 215.0k
Lisa Paley	President of North America	no data	Veri yok	0.00044% £ 150.2k
Franck Riot	Chief R&D Officer	no data	Veri yok	0.00024% £ 81.9k

0.3yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: HLN 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.3 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Brian McNamara	CEO & Executive Director	2.5yrs	UK£5.76m	0.014% £ 4.8m
Dawn Allen	CFO & Director	no data	Veri yok	Veri yok
Dame Cox	Independent Non-Executive Director	2.3yrs	UK£125.40k	Veri yok
Manvinder Banga	Senior Independent Non-Executive Director	2.3yrs	UK£145.60k	0.0036% £ 1.2m
Tracy Clarke	Independent Non-Executive Director	2.3yrs	UK£135.20k	0.00014% £ 47.8k
Alan James Stewart	Independent Non-Executive Director	less than a year	Veri yok	Veri yok
David Lewis	Independent Non-Executive Chair	2.5yrs	UK£705.60k	0.0010% £ 358.4k
David Denton	Non-Executive Director	1.7yrs	UK£200.00	Veri yok
Bryan Supran	Non-Executive Director	2.3yrs	UK£6.10k	0.00055% £ 187.7k
Nancy Avila	Independent Non-Executive Director	less than a year	Veri yok	Veri yok
Marie-Anne Aymerich	Independent Non-Executive Director	2.3yrs	UK£123.00k	0.00031% £ 105.8k
Asmita Dubey	Independent Non-Executive Director	2.3yrs	UK£96.80k	Veri yok

2.3yrs

Ortalama Görev Süresi

58.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: HLN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.3 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Haleon Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Haleon plc Announces Directorate Change

Haleon plc Announces Chief Financial Officer Changes

Haleon plc Announces Management Changes

Haleon plc, Annual General Meeting, May 08, 2024

High number of new and inexperienced directors

Independent Non-Executive Chair recently bought UK£100k worth of stock

Recent updates

Haleon plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Calculating The Fair Value Of Haleon plc (LON:HLN)

Is Haleon (LON:HLN) Using Too Much Debt?

Haleon plc (LSE:HLN) commences an Equity Buyback Plan for 455,701,825 shares, representing 4.99% of its issued share capital., under the authorization approved on May 8, 2024.

Pfizer Intends to Sell About 540 Million Ordinary Shares in Haleon

Dr. Reddy'S Laboratories S.A. completed the acquisition of Northstar Switzerland SARL from Haleon plc (LSE:HLN).

Haleon (LON:HLN) Might Have The Makings Of A Multi-Bagger

Haleon Announces the Launch of Eroxon®?, the First and Only Fda Cleared Otc Gel for Erectile Dysfunction, Available for U.S. Pre Order Without A Prescription

Haleon plc (LSE:HLN) commences an Equity Buyback Plan for 913,000,000 shares, representing 10% of its issued share capital, under the authorization approved on May 8, 2024.

First half dividend increased to UK£0.02

Haleon plc (LSE:HLN) commences an Equity Buyback Plan for 913,000,000 shares, representing 10% of its issued share capital, under the authorization approved on May 8, 2024.

Second quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Haleon plc Provides Earnings Guidance for the Fiscal Year 2024

Haleon plc to Report Fiscal Year 2024 Results on Mar 05, 2025

Dr. Reddy'S Laboratories S.A. signed a definitive agreement to acquire Northstar Switzerland SARL from Haleon plc (LSE:HLN) for £500 million.

Estimating The Fair Value Of Haleon plc (LON:HLN)

GSK Announces Intention to Sell Approximately 385 Million Shares in Haleon

Haleon plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS exceeds analyst expectations

Haleon plc Announces Directorate Change

Now 20% overvalued after recent price rise

Haleon plc Announces Chief Financial Officer Changes

Haleon plc Announces Management Changes

Haleon plc has filed a Follow-on Equity Offering.

Haleon plc has filed a Follow-on Equity Offering.

Haleon plc has filed a Follow-on Equity Offering.

Sensodyne Introduces New Triple Action Formula: 'Sensitivity Gum & Enamel'

Upcoming dividend of UK£0.042 per share

Haleon plc's (LON:HLN) Popularity With Investors Is Clear

Final dividend increased to UK£0.042

Haleon plc, Annual General Meeting, May 08, 2024

Now 23% overvalued

Haleon plc Proposes Final Dividend for Fiscal Year 2023, Payable on 16 May 2024

Calculating The Intrinsic Value Of Haleon plc (LON:HLN)

Dr Reddy's Laboratories Reportedly Eyes Mega Brand in UK

Haleon (LON:HLN) Might Have The Makings Of A Multi-Bagger

Third quarter 2023 earnings released: EPS: UK£0.04 (vs UK£0.037 in 3Q 2022)

Haleon plc to Report Fiscal Year 2023 Results on Feb 29, 2024

An unknown buyer acquired a 2.923787% stake in Haleon plc from GSK plc for approximately £890 million.

An unknown buyer acquired a 2.923787% stake in Haleon plc from GSK plc for approximately £890 million.

Estimating The Intrinsic Value Of Haleon plc (LON:HLN)

Upcoming dividend of UK£0.018 per share at 1.1% yield

Haleon (LON:HLN) Shareholders Will Want The ROCE Trajectory To Continue

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Haleon plc Provides Earnings Guidance for the Fiscal Year 2023

Haleon Reportedly Exploring Sale of Nicotine Gum Business

First quarter 2023 earnings released: EPS: UK£0.042 (vs UK£0.037 in 1Q 2022)

Haleon plc's (LON:HLN) Intrinsic Value Is Potentially 23% Below Its Share Price

High number of new and inexperienced directors

Haleon plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Independent Non-Executive Chair recently bought UK£100k worth of stock

Investors Can Find Comfort In Haleon's (LON:HLN) Earnings Quality

Full year 2022 earnings released: EPS: UK£0.12 (vs UK£0.15 in FY 2021)

Haleon plc Announces Board Changes

Calculating The Fair Value Of Haleon plc (LON:HLN)

Third quarter 2022 earnings released

Haleon plc Provides Revenue Guidance for Fiscal 2022

Second quarter 2022 earnings released

Haleon plc Provides Revenue Guidance for Fiscal 2022

Haleon Introduces Advil PLUS Acetaminophen to Canadians, Combining Two Trusted Pain Relievers into One Convenient Tablet

Haleon plc to Report First Half, 2022 Results on Sep 19, 2022

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş